EyePoint Pharmaceuticals, Inc.

Free public records show EyePoint Pharmaceuticals, Inc. in 1 of the markets we cover. It is not a key player in our research.

[1] ClinicalTrials.gov, Studies led by EyePoint Pharmaceuticals, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.

Public data

Free public data on EyePoint Pharmaceuticals, Inc.

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

Company facts

Home country
United States
Stock listing
NASDAQ: PSDV
Legal name
EYEPOINT, INC.
Type
Medical devices

Source: Wikidata, Company record Q7120927. Retrieved 13 Nov 2026.

Source: GLEIF, Legal entity record, LEI 549300QE1RU34T50MR69. Retrieved 13 Nov 2026.

Source: SEC EDGAR, Company filings, CIK 1314102. Retrieved 13 Nov 2026.

Trials over time

Studies EyePoint Pharmaceuticals, Inc. leads, by the year they started and their phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • No phase (devices, observational)

Source: ClinicalTrials.gov, Studies with EyePoint Pharmaceuticals, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.

Markets where public records show them

Markets we cover where free public records show EyePoint Pharmaceuticals, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.

Healthcare Topics

The topics of the markets EyePoint Pharmaceuticals, Inc. is in.

All healthcare topics

Search all reports for EyePoint Pharmaceuticals, Inc. All companies